75
Views
5
CrossRef citations to date
0
Altmetric
Rapid Communication

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders

, , , , &
Pages 121-127 | Published online: 28 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhe Wang, Li Wang, Ren-ai Xu, Yun-yun Zhan, Cheng-ke Huang, Da-peng Dai, Jian-ping Cai & Guo-xin Hu. (2016) Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro. Drug Design, Development and Therapy 10, pages 1909-1916.
Read now

Articles from other publishers (4)

Xiao-lin Li, Shan-qing Huang, Tao Xiao, Xi-pei Wang, Wan Kong, Shu-jing Liu, Zi Zhang, Ye Yang, Shan-shan Huang, Xiao-jia Ni, Hao-yang Lu, Ming Zhang, Yu-guan Wen & De-wei Shang. (2022) Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients. Frontiers in Pharmacology 13.
Crossref
Shigenori Wada, Seiya Kagatani & Hiroaki Nakagami. (2021) Quantitative estimation of intra-subject variability in bioequivalence studies of generic solid oral dosage forms by multiple regression analysis. Journal of Drug Delivery Science and Technology 64, pages 102656.
Crossref
Michael R Jablonski, Nina King, Yongbao Wang, Joel G Winner, Lucas R Watterson, Sandra Gunselman & Bryan M Dechairo. (2018) Analytical validation of a psychiatric pharmacogenomic test. Personalized Medicine 15:3, pages 189-197.
Crossref
Wei-Chun Jim Hsu, Carol Lynn Nilsson & Fernanda Laezza. (2014) Role of the Axonal Initial Segment in Psychiatric Disorders: Function, Dysfunction, and Intervention. Frontiers in Psychiatry 5.
Crossref